RT Book, Section A1 Lee Tran, Catherine A1 Tran, Mark M. A1 Wang, Timothy S. A2 Avram, Marc R. A2 Avram, Mathew M. A2 Ratner, Désirée SR Print(0) ID 1175094556 T1 Management of Advanced Nonmelanoma Skin Cancer T2 Procedural Dermatology YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071795067 LK dermatology.mhmedical.com/content.aspx?aid=1175094556 RD 2024/11/06 AB Skin cancers are divided into two main groups: malignant melanoma (MM) and nonmelanoma skin cancer (NMSC). The term “NMSC” encompasses a wide variety of skin cancers including basal cell carcinomas (BCC), cutaneous squamous cell carcinomas (cSCC), dermatofibrosarcoma protuberans (DFSP), cutaneous lymphomas, adnexal tumors, and Merkel cell carcinoma (MCC), and only excludes malignancies involving melanocytes. BCC and cSCC comprise the vast majority of NMSC tumors (estimated between 75% and 80% and 20% and 25%, respectively)1,2 and their incidence is approximately 18 to 20 times higher than that of MM.3 This chapter will focus on the management of advanced BCC, cSCC, DFSP, and MCC.